Hasham Sumera N, Willing Marcia C, Guo Dong-chuan, Muilenburg Ann, He Rumin, Tran Van T, Scherer Steven E, Shete Sanjay S, Milewicz Dianna M
Department of Internal Medicine, University of Texas Medical School at Houston, USA.
Circulation. 2003 Jul 1;107(25):3184-90. doi: 10.1161/01.CIR.0000078634.33124.95. Epub 2003 Jun 23.
Familial thoracic aortic aneurysms and dissections (TAAD) occur as part of known syndromes such as Marfan syndrome but can also be inherited in families in an autosomal dominant manner as an isolated condition. Previous studies have mapped genes causing nonsyndromic familial TAAD to 5q13-15 (TAAD1) and 11q23.2-q24 (FAA1). Further genetic heterogeneity for the condition was evident by the presence of TAAD in some families not linked to these known loci.
A 4-generation family with dominant mode of inheritance of TAAD was studied. Affected status was determined by dilation of the ascending aorta, surgical repair of an aneurysm or dissection, or death as the result of aortic dissection. None of the family members evaluated met the diagnostic criteria for Marfan syndrome. After exclusion of known loci for familial TAAD, a genome-wide scan was carried out to map the defective gene causing the disease in the family. A locus was mapped to a 25-cM region on 3p24-25 with a maximum multipoint logarithm of the odds score of 4.28.
A third locus for nonsyndromic TAAD was mapped to 3p24-25 and termed the TAAD2 locus. This locus overlaps a previously mapped second locus for Marfan syndrome, termed the MFS2 locus. Future characterization of the TAAD2 gene will determine if TAAD2 is allelic to MFS2. In addition, identification of the TAAD2 gene will improve the presymptomatic diagnosis of individuals with this life-threatening genetic syndrome and provide information concerning the pathogenesis of the disease.
家族性胸主动脉瘤和主动脉夹层(TAAD)作为已知综合征(如马凡综合征)的一部分出现,但也可作为一种孤立病症以常染色体显性方式在家族中遗传。先前的研究已将导致非综合征性家族性TAAD的基因定位到5q13 - 15(TAAD1)和11q23.2 - q24(FAA1)。由于在一些与这些已知基因座不连锁的家族中存在TAAD,该病症的进一步遗传异质性很明显。
研究了一个具有TAAD显性遗传模式的四代家族。通过升主动脉扩张、动脉瘤或主动脉夹层的手术修复或主动脉夹层导致的死亡来确定患病状态。所有接受评估的家庭成员均不符合马凡综合征的诊断标准。在排除家族性TAAD的已知基因座后,进行了全基因组扫描以定位导致该家族疾病的缺陷基因。一个基因座被定位到3p24 - 25上一个25厘摩的区域,最大多点对数优势分数为4.28。
非综合征性TAAD的第三个基因座被定位到3p24 - 25,并命名为TAAD2基因座。该基因座与先前定位的马凡综合征的第二个基因座(称为MFS2基因座)重叠。TAAD2基因的未来特征分析将确定TAAD2是否与MFS2等位。此外,TAAD2基因的鉴定将改善对患有这种危及生命的遗传综合征个体的症状前诊断,并提供有关该疾病发病机制的信息。